Combo Therapy Shines in Colon Cancer
SAN FRANCISCO (MedPage Today) -- First-line combination bevacizumab and capecitabine therapy may be an optimal first-line treatment for metastatic colorectal cancer in treatment-naive older patients, researchers reported here.
Source: MedPage Today State Required CME - Category: Consumer Health News Source Type: news
More News: Avastin | Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Health | Xeloda